Ardelyx Presents Positive Data Further Supporting Efficacy a

Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of hyperphosphatemia XPHOZAH consistently lowered serum... | April 12, 2023

Related Keywords

United States , Japan , Canada , China , American , Fosun Pharma , Laura Williams , Exchange Commission , National Kidney Foundation , Facebook , Nasdaq , Exchange Commission On , Twitter , Ardelyx Inc , Linkedin , Clinical Meetings , Hoc Analyses , Serum Phosphate Changes , African American , White Patients , In Depth Analysis , Tenapanor Treatment , Chronic Kidney Disease , Kyowa Kirin , Knight Therapeutics , Private Securities Reform Act , Annual Report , Ardelyx , Nc Stock Exchange , News , Information , Press Release , Three , Posters , Support , The , Important , Sole , Hat , Novel , Phosphate , Absorption , Would , Potentially , Play , N , Treatment , F , Hyperphosphatemia , Xphozah , Consistently , Owered Ardx Us0396971071 ,